Indaptus Therapeutics Analyst Ratings
BenzingaApr 15 06:06 ET
Buy Rating for Indaptus Therapeutics: Promising Oncology Breakthrough With Decoy20 Platform
TipRanksApr 12 15:05 ET
Buy Rating Affirmed for Indaptus Therapeutics Amid Positive Clinical and Financial Outlook
TipRanksMar 14 13:55 ET
Buy Rating Affirmed on Indaptus Therapeutics as Decoy20 Advances in Phase 1 With Promising Developments
TipRanksMar 6 14:15 ET
Analysts Conflicted on These Healthcare Names: Ventyx Biosciences (VTYX) and Indaptus Therapeutics (INDP)
TipRanksNov 7, 2023 09:50 ET
Indaptus Therapeutics: Promising Phase 1 Results and Optimistic Valuation Bolster Buy Rating
TipRanksNov 3, 2023 06:39 ET
Analysts' Opinions Are Mixed on These Healthcare Stocks: Revance Therapeutics (RVNC), Myriad Genetics (MYGN) and Indaptus Therapeutics (INDP)
TipRanksSep 20, 2023 06:32 ET
Indaptus Therapeutics Analyst Ratings
BenzingaSep 20, 2023 06:32 ET
Analysts' Top Healthcare Picks: Indaptus Therapeutics (INDP), Achieve Life Sciences (ACHV)
TipRanksAug 15, 2023 11:30 ET
HC Wainwright & Co. Reiterates Buy on Indaptus Therapeutics, Maintains $12 Price Target
BenzingaAug 15, 2023 06:55 ET
Indaptus Therapeutics Analyst Ratings
BenzingaAug 15, 2023 06:55 ET
H.C. Wainwright Sticks to Its Buy Rating for Indaptus Therapeutics (INDP)
TipRanksAug 15, 2023 06:35 ET
Maxim Group Remains a Buy on Indaptus Therapeutics (INDP)
TipRanksAug 11, 2023 11:25 ET
Indaptus Therapeutics Analyst Ratings
BenzingaAug 11, 2023 07:13 ET
Indaptus Therapeutics (INDP) Receives a Buy From H.C. Wainwright
TipRanksAug 8, 2023 06:25 ET
HC Wainwright & Co. Reiterates Buy on Indaptus Therapeutics, Maintains $12 Price Target
BenzingaAug 8, 2023 06:20 ET
Indaptus Therapeutics Analyst Ratings
BenzingaAug 8, 2023 06:19 ET
Analysts Are Bullish on Top Healthcare Stocks: Nkarta (NKTX), Indaptus Therapeutics (INDP)
TipRanksMay 12, 2023 12:40 ET
Indaptus Therapeutics (INDP) Gets a Buy From H.C. Wainwright
TipRanksMay 12, 2023 08:15 ET
What 4 Analyst Ratings Have To Say About Indaptus Therapeutics
BenzingaMay 4, 2023 16:01 ET
No Data
No Data